Trinity Biotech PLC (TRIB)
1.685
-0.06
(-3.71%)
USD |
NASDAQ |
May 02, 16:00
1.685
0.00 (0.00%)
After-Hours: 18:12
Trinity Biotech Max Drawdown (5Y): 96.69% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 96.69% |
March 31, 2024 | 96.69% |
February 29, 2024 | 96.69% |
January 31, 2024 | 96.69% |
December 31, 2023 | 96.69% |
November 30, 2023 | 96.69% |
October 31, 2023 | 96.69% |
September 30, 2023 | 96.69% |
August 31, 2023 | 96.69% |
July 31, 2023 | 96.69% |
June 30, 2023 | 96.69% |
May 31, 2023 | 96.69% |
April 30, 2023 | 96.69% |
March 31, 2023 | 96.69% |
February 28, 2023 | 96.69% |
January 31, 2023 | 96.69% |
December 31, 2022 | 96.69% |
November 30, 2022 | 96.69% |
October 31, 2022 | 96.69% |
September 30, 2022 | 96.69% |
August 31, 2022 | 96.69% |
July 31, 2022 | 96.69% |
June 30, 2022 | 96.69% |
May 31, 2022 | 96.69% |
April 30, 2022 | 96.69% |
Date | Value |
---|---|
March 31, 2022 | 96.69% |
February 28, 2022 | 96.69% |
January 31, 2022 | 96.69% |
December 31, 2021 | 96.69% |
November 30, 2021 | 96.69% |
October 31, 2021 | 96.69% |
September 30, 2021 | 96.69% |
August 31, 2021 | 96.69% |
July 31, 2021 | 96.69% |
June 30, 2021 | 96.69% |
May 31, 2021 | 96.69% |
April 30, 2021 | 96.69% |
March 31, 2021 | 96.69% |
February 28, 2021 | 96.69% |
January 31, 2021 | 96.69% |
December 31, 2020 | 96.69% |
November 30, 2020 | 96.69% |
October 31, 2020 | 96.69% |
September 30, 2020 | 96.69% |
August 31, 2020 | 96.69% |
July 31, 2020 | 96.69% |
June 30, 2020 | 96.69% |
May 31, 2020 | 96.69% |
April 30, 2020 | 96.69% |
March 31, 2020 | 96.69% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
92.14%
Minimum
May 2019
96.69%
Maximum
Mar 2020
96.37%
Average
96.69%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Avadel Pharmaceuticals PLC | 92.53% |
Amarin Corp PLC | 97.26% |
DBV Technologies SA | 97.67% |
Adaptimmune Therapeutics PLC | 96.57% |
Akari Therapeutics PLC | 98.58% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -48.79 |
Beta (5Y) | 1.240 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 79.34% |
Historical Sharpe Ratio (5Y) | -0.4407 |
Historical Sortino (5Y) | -0.9707 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.36% |